Viewing Study NCT00963820


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-02-04 @ 4:43 PM
Study NCT ID: NCT00963820
Status: COMPLETED
Last Update Posted: 2018-01-10
First Post: 2009-08-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral IXAZOMIB in Adult Patients With Relapsed and Refractory Multiple Myeloma
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed multiple myeloma View
None Refractory multiple myeloma View
None Drug therapy View